Last edition
News about "Novartis AAD 2026 data"
Novartis Presents New Data on Skin Disease Treatment at AAD 2026
Novartis presents new AAD 2026 data showing early symptom relief and long-term control in skin diseases, with Rhapsido REMIX analysis in CSU and Cosentyx data in hidradenitis suppurativa and psoriasis.
Novartis AAD 2026 Data | 25/03/2026 | By News Bureau | 215
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members